233 related articles for article (PubMed ID: 28619760)
21. SOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage.
Hong X; Liu W; Song R; Shah JJ; Feng X; Tsang CK; Morgan KM; Bunting SF; Inuzuka H; Zheng XF; Shen Z; Sabaawy HE; Liu L; Pine SR
Nucleic Acids Res; 2016 Oct; 44(18):8855-8869. PubMed ID: 27566146
[TBL] [Abstract][Full Text] [Related]
22. The E3 ubiquitin ligases β-TrCP and FBXW7 cooperatively mediates GSK3-dependent Mcl-1 degradation induced by the Akt inhibitor API-1, resulting in apoptosis.
Ren H; Koo J; Guan B; Yue P; Deng X; Chen M; Khuri FR; Sun SY
Mol Cancer; 2013 Nov; 12():146. PubMed ID: 24261825
[TBL] [Abstract][Full Text] [Related]
23. Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation.
Yao S; Xu F; Chen Y; Ge Y; Zhang F; Huang H; Li L; Lin D; Luo X; Xu J; Luo D; Zhu X; Liu Y
J Exp Clin Cancer Res; 2017 Jan; 36(1):10. PubMed ID: 28069035
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis.
Arai S; Jonas O; Whitman MA; Corey E; Balk SP; Chen S
Clin Cancer Res; 2018 Nov; 24(21):5458-5470. PubMed ID: 30021909
[No Abstract] [Full Text] [Related]
25. Y-632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo.
Wang W; Liu Y; Zhao Z; Xie C; Xu Y; Hu Y; Quan H; Lou L
Cancer Sci; 2016 Jun; 107(6):782-90. PubMed ID: 27002306
[TBL] [Abstract][Full Text] [Related]
26. Negative regulation of HIF-1α by an FBW7-mediated degradation pathway during hypoxia.
Cassavaugh JM; Hale SA; Wellman TL; Howe AK; Wong C; Lounsbury KM
J Cell Biochem; 2011 Dec; 112(12):3882-90. PubMed ID: 21964756
[TBL] [Abstract][Full Text] [Related]
27. FBW7 Inhibits Myeloid Differentiation in Acute Myeloid Leukemia via GSK3-Dependent Ubiquitination of PU.1.
Mishra M; Thacker G; Sharma A; Singh AK; Upadhyay V; Sanyal S; Verma SP; Tripathi AK; Bhatt MLB; Trivedi AK
Mol Cancer Res; 2021 Feb; 19(2):261-273. PubMed ID: 33188146
[TBL] [Abstract][Full Text] [Related]
28. FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1.
Hu Q; Qin Y; Zhang B; Liang C; Ji S; Shi S; Xu W; Xiang J; Liang D; Ni Q; Yu X; Xu J
Oncol Rep; 2017 Oct; 38(4):2069-2077. PubMed ID: 28765935
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL receptor tyrosine kinase degradation.
Krishnamoorthy GP; Guida T; Alfano L; Avilla E; Santoro M; Carlomagno F; Melillo RM
J Biol Chem; 2013 Jun; 288(24):17481-94. PubMed ID: 23629654
[TBL] [Abstract][Full Text] [Related]
30. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction.
Inuzuka H; Shaik S; Onoyama I; Gao D; Tseng A; Maser RS; Zhai B; Wan L; Gutierrez A; Lau AW; Xiao Y; Christie AL; Aster J; Settleman J; Gygi SP; Kung AL; Look T; Nakayama KI; DePinho RA; Wei W
Nature; 2011 Mar; 471(7336):104-9. PubMed ID: 21368833
[TBL] [Abstract][Full Text] [Related]
31. DNA Damage Promotes TMPRSS2-ERG Oncoprotein Destruction and Prostate Cancer Suppression via Signaling Converged by GSK3β and WEE1.
Hong Z; Zhang W; Ding D; Huang Z; Yan Y; Cao W; Pan Y; Hou X; Weroha SJ; Karnes RJ; Wang D; Wu Q; Wu D; Huang H
Mol Cell; 2020 Sep; 79(6):1008-1023.e4. PubMed ID: 32871104
[TBL] [Abstract][Full Text] [Related]
32. A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells.
Wei S; Yang HC; Chuang HC; Yang J; Kulp SK; Lu PJ; Lai MD; Chen CS
J Biol Chem; 2008 Sep; 283(39):26759-70. PubMed ID: 18650423
[TBL] [Abstract][Full Text] [Related]
33. Recent insight into the role of FBXW7 as a tumor suppressor.
Yumimoto K; Nakayama KI
Semin Cancer Biol; 2020 Dec; 67(Pt 2):1-15. PubMed ID: 32113998
[TBL] [Abstract][Full Text] [Related]
34. FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells.
Lin J; Ji A; Qiu G; Feng H; Li J; Li S; Zou Y; Cui Y; Song C; He H; Lu Y
Cancer Sci; 2018 Apr; 109(4):1001-1011. PubMed ID: 29427543
[TBL] [Abstract][Full Text] [Related]
35. Trim17-mediated ubiquitination and degradation of Mcl-1 initiate apoptosis in neurons.
Magiera MM; Mora S; Mojsa B; Robbins I; Lassot I; Desagher S
Cell Death Differ; 2013 Feb; 20(2):281-92. PubMed ID: 22976837
[TBL] [Abstract][Full Text] [Related]
36. Physiological functions of FBW7 in cancer and metabolism.
Shimizu K; Nihira NT; Inuzuka H; Wei W
Cell Signal; 2018 Jun; 46():15-22. PubMed ID: 29474981
[TBL] [Abstract][Full Text] [Related]
37. EglN2 contributes to triple negative breast tumorigenesis by functioning as a substrate for the FBW7 tumor suppressor.
Takada M; Zhuang M; Inuzuka H; Zhang J; Zurlo G; Zhang J; Zhang Q
Oncotarget; 2017 Jan; 8(4):6787-6795. PubMed ID: 28036276
[TBL] [Abstract][Full Text] [Related]
38. Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis.
Huang HL; Weng HY; Wang LQ; Yu CH; Huang QJ; Zhao PP; Wen JZ; Zhou H; Qu LH
Mol Cancer Ther; 2012 May; 11(5):1155-65. PubMed ID: 22389469
[TBL] [Abstract][Full Text] [Related]
39. The Tumor Suppressor FBW7 and the Vitamin D Receptor Are Mutual Cofactors in Protein Turnover and Transcriptional Regulation.
Salehi-Tabar R; Memari B; Wong H; Dimitrov V; Rochel N; White JH
Mol Cancer Res; 2019 Mar; 17(3):709-719. PubMed ID: 30606768
[TBL] [Abstract][Full Text] [Related]
40. Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization.
Ding Q; He X; Hsu JM; Xia W; Chen CT; Li LY; Lee DF; Liu JC; Zhong Q; Wang X; Hung MC
Mol Cell Biol; 2007 Jun; 27(11):4006-17. PubMed ID: 17387146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
